Harvard Bioscience (HBIO) Non-Current Assets (2016 - 2025)
Harvard Bioscience (HBIO) has disclosed Non-Current Assets for 16 consecutive years, with $19.4 million as the latest value for Q4 2025.
- Quarterly Non-Current Assets fell 12.61% to $19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.4 million through Dec 2025, down 12.61% year-over-year, with the annual reading at $19.4 million for FY2025, 12.61% down from the prior year.
- Non-Current Assets for Q4 2025 was $19.4 million at Harvard Bioscience, down from $34.2 million in the prior quarter.
- The five-year high for Non-Current Assets was $102.0 million in Q1 2021, with the low at $19.4 million in Q4 2025.
- Average Non-Current Assets over 5 years is $67.8 million, with a median of $84.7 million recorded in 2024.
- The sharpest move saw Non-Current Assets decreased 1.63% in 2022, then plummeted 59.52% in 2025.
- Over 5 years, Non-Current Assets stood at $37.5 million in 2021, then dropped by 19.99% to $30.0 million in 2022, then fell by 17.98% to $24.6 million in 2023, then dropped by 9.8% to $22.2 million in 2024, then dropped by 12.61% to $19.4 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods came in at $19.4 million, $34.2 million, and $35.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.